Trial Profile
A retrospective trial assessing effect of mogamulizumab on severe acute graft-versus-host disease development in Adult T-cell leukemia/lymphoma patients treated with mogamulizumab prior to allogeneic hematopoietic stem cell transplantation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Mogamulizumab (Primary)
- Indications Adult T-cell leukaemia-lymphoma; Graft-versus-host disease
- Focus Adverse reactions
- 04 Feb 2016 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology